Abiopharma

New Form 3 - IQVIA HOLDINGS INC. Filed: 2026-01-09 AccNo: 0001628280-26-001698 Size: 19 KB

New Form 3 - IQVIA HOLDINGS INC. Filed: 2026-01-09 AccNo: 0001628280-26-001697 Size: 15 KB

Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference

New Form 3 - IQVIA HOLDINGS INC. Filed: 2026-01-09 AccNo: 0001628280-26-001695 Size: 16 KB

ReconAfrica Announces Adoption of Shareholder Rights Plan

New Form 3 - IQVIA HOLDINGS INC. Filed: 2026-01-09 AccNo: 0001628280-26-001694 Size: 19 KB

Connelly Stephen 🟢 acquired 1.1M shares (1 derivative) of Equillium, Inc. (EQ) at $1.31 ($1.5M) Transaction Date: Jan 07, 2026 | Filing ID: 000002

Shukla Sanjay 🟢 acquired 1.5M shares (1 derivative) of aTYR PHARMA INC (ATYR) at $0.71 ($1.1M) Transaction Date: Jan 09, 2026 | Filing ID: 009161

Broadfoot Jill Marie 🟢 acquired 412.5K shares (1 derivative) of aTYR PHARMA INC (ATYR) at $0.71 Transaction Date: Jan 09, 2026 | Filing ID: 009156

Zedelmayer Christine 🟢 acquired 500.0K shares (1 derivative) of Equillium, Inc. (EQ) at $1.31 Transaction Date: Jan 07, 2026 | Filing ID: 000001

Lippis Daniel J. 🟡 adjusted position in 1.0K shares (1 derivative) of Edwards Lifesciences Corp (EW) at $85.70 Transaction Date: Jan 09, 2026 | Filing ID: 000558

DENYES NANCY 🟢 acquired 412.5K shares (1 derivative) of aTYR PHARMA INC (ATYR) at $0.71 Transaction Date: Jan 09, 2026 | Filing ID: 009152

Steel Bruce D. 🟢 acquired 1.8M shares (1 derivative) of Equillium, Inc. (EQ) at $1.31 ($2.3M) Transaction Date: Jan 07, 2026 | Filing ID: 000001

Tom Penny 🟡 adjusted position in 443.5K shares (1 derivative) of Equillium, Inc. (EQ) at $1.31 Transaction Date: Jan 07, 2026 | Filing ID: 000001

ArrowMark Financial Corp. Announces Monthly Cash Distribution of $0.15 per Share for January 2026